US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apogee Therapeutics

39.11

-0.2000-0.51%

Post-market: 39.120.0100+0.03%17:53 EDT

Volume:787.44K

Turnover:31.06M

Market Cap:2.33B

PE:-10.89

High:40.19

Open:39.47

Low:38.66

Close:39.31

Loading ...

Overview Company News Filings

Apogee Therapeutics (APGE) Receives a Buy from BTIG

Positive Phase 2 Data from APGE Bolsters Spyre Therapeutics’ Strategy and Stock Appeal

Regeneron's Blockbuster Dupixent Faces a New Rival -- Barrons.com

Corvus 'Undervalued' Following Atopic Dermatitis Data From Apogee, Mizuho Securities Says

MT Newswires Live

Jefferies Sticks to Its Buy Rating for Apogee Therapeutics (APGE)

Apogee Therapeutics Inc : Jefferies Raises Target Price to $96 From $88

THOMSON REUTERS

Promising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target

Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating

Top Midday Decliners

MT Newswires Live

Optimistic Buy Recommendation for Apogee Therapeutics Driven by Promising APG777 Data and Strong Financial Position

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Apogee Therapeutics Shares Reverse Premarket Gains; Last Down 15.7%

THOMSON REUTERS

Stock Track | Apogee Therapeutics Plummets 5.18% Despite Positive Phase 2 Trial Results for Atopic Dermatitis Drug

Stock Track | Apogee Therapeutics Plummets 5.18% Despite Positive Phase 2 Trial Results for Atopic Dermatitis Drug

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Look Ahead to US Trade Pact Announcements

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Constellation Brands, KalVista Pharma

Top Premarket Gainers

MT Newswires Live

Apogee Therapeutics Rise on Positive Data from Dermatitis Treatment Trials

Apogee Therapeutics Reports Positive Phase 2 Trial Results

BUZZ-Apogee Therapeutics jumps after eczema drug meets main goal in mid-stage study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/APGE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":39.11,"timestamp":1753128000000,"preClose":39.31,"halted":0,"volume":787444,"hourTrading":{"tag":"盘后","latestPrice":39.12,"preClose":39.11,"latestTime":"17:53 EDT","volume":22605,"amount":884108.676,"timestamp":1753134801088},"delay":0,"floatShares":38759800,"shares":59534058,"eps":-3.591044,"marketStatus":"Post-Mkt","change":-0.2,"latestTime":"07-21 18:34:07 EDT","open":39.47,"high":40.19,"low":38.66,"amount":31058413.49464,"amplitude":0.038921,"askPrice":40,"askSize":2,"bidPrice":38.85,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.591044,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1753142400000},"marketStatusCode":4,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":39.31,"preHourTrading":{"tag":"盘前","latestPrice":39.761,"preClose":39.31,"latestTime":"09:06 EDT","volume":597,"amount":23612.643101999998,"timestamp":1753103182615},"postHourTrading":{"tag":"盘后","latestPrice":39.12,"preClose":39.11,"latestTime":"17:53 EDT","volume":22605,"amount":884108.676,"timestamp":1753134801088},"volumeRatio":1.040999,"impliedVol":0.7085,"impliedVolPercentile":0.604},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":38759800,"roa":"-19.65%","roe":"-27.85%","lyrEps":-3.300106,"volumeRatio":1.040999,"shares":59534058,"dividePrice":0,"high":40.19,"amplitude":0.038921,"preClose":39.31,"low":38.66,"week52Low":26.2,"pbRate":"3.46","week52High":63.5,"institutionHeld":0,"latestPrice":39.11,"committee":0.923077,"eps":-3.591044,"divideRate":0,"volume":787444,"delay":0,"ttmEps":-3.591044,"open":39.47,"prevYearClose":45.3,"prevWeekClose":39.31,"prevMonthClose":43.43,"prevQuarterClose":43.43,"fiveDayClose":38.88,"twentyDayClose":41.96,"sixtyDayClose":36.53},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550969574","title":"Apogee Therapeutics (APGE) Receives a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2550969574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550969574?lang=en_us&edition=fundamental","pubTime":"2025-07-12 03:55","pubTimestamp":1752263710,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison maintained a Buy rating on Apogee Therapeutics today and set a price target of $115.00. The company’s shares opened to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/apogee-therapeutics-apge-receives-a-buy-from-btig-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/apogee-therapeutics-apge-receives-a-buy-from-btig-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2550635286","title":"Positive Phase 2 Data from APGE Bolsters Spyre Therapeutics’ Strategy and Stock Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550635286?lang=en_us&edition=fundamental","pubTime":"2025-07-09 17:46","pubTimestamp":1752054380,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on SYRE stock, giving a Buy rating on June 23. Faisal Khurshid’s ratin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-phase-2-data-from-apge-bolsters-spyre-therapeutics-strategy-and-stock-appeal-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-phase-2-data-from-apge-bolsters-spyre-therapeutics-strategy-and-stock-appeal-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","BK4588","BK4600","APGE","BK4595","BK4585","STRK","BK4139","BK4596","BK4023"],"gpt_icon":0},{"id":"2550207645","title":"Regeneron's Blockbuster Dupixent Faces a New Rival -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2550207645","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550207645?lang=en_us&edition=fundamental","pubTime":"2025-07-09 03:31","pubTimestamp":1752003060,"startTime":"0","endTime":"0","summary":"With $17 billion in annual sales, Dupixent is a franchise drug for its 50/50 owners Sanofi and Regeneron Pharmaceuticals. So rivals have lined up to challenge the antibody treatment against autoimmune disorders such as dermatitis and asthma.Monday, Apogee Therapeutics reported quite competitive results among dermatitis patients in its Phase 2 trial of a drug that might require fewer injections than Dupixent. Guggenheim Securities analyst Seamus Fernandez said the drug is on track to be a best-in-class treatment and reaffirmed Apogee as his best investment idea.Others disagreed. Apogee stock sank 17% in heavy trading, to end Monday at $39. Tuesday morning, it slipped another couple of bucks, while Regeneron rose 3%, to $556.Apogee's APG777 antibody sops up IL-13, an immune system molecule that causes much of the itchy scaling of dermatitis. Over 16 weeks of the study, 42% of patients saw improvement on 75% of the skin area affected by eczema, compared with a placebo. Lilly's drug delive","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","LU0466842654.USD","LU2089984988.USD","LU2265009873.SGD","LU2357305700.SGD","LU0417517546.SGD","LU2237443382.USD","LU1720051017.SGD","SG9999014906.USD","LU1366192091.USD","LU0096364046.USD","LU2237443622.USD","APGE","BK4534","LU0689472784.USD","LU2324357040.USD","LU0323591593.USD","IE0002141913.USD","REGN","LU2750360641.GBP","SG9999014898.SGD","LU2750360997.AUD","LU0106261372.USD","LU0234572021.USD","GB00BDT5M118.USD","LU0122379950.USD","LU1064131342.USD","SNY","LU2456880835.USD","LU0053666078.USD","LU2112291526.USD","LU2552382132.HKD","LU2237443978.SGD","LU1868836914.USD","IE00B2B36J28.USD","LU2023250504.SGD","LU1291159041.SGD","LU1093756325.SGD","LU2237438978.USD","BK4139","IE00BJLML261.HKD","IE0009355771.USD","SG9999015952.SGD","SGXZ57979304.SGD","LU0471298694.HKD","SG9999015978.USD","IE00BFTCPJ56.SGD","BK4581","LU0256863811.USD"],"gpt_icon":1},{"id":"2549529452","title":"Corvus 'Undervalued' Following Atopic Dermatitis Data From Apogee, Mizuho Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2549529452","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549529452?lang=en_us&edition=fundamental","pubTime":"2025-07-08 23:30","pubTimestamp":1751988659,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals (CRVS) stock remains \"undervalued and compelling\" compared with peers like Apogee Therapeutics (APGE), whose latest data on its experimental atopic dermatitis drug APG777 failed","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","APGE","CRVS","BK4139","BK4207","MFG"],"gpt_icon":0},{"id":"2549525340","title":"Jefferies Sticks to Its Buy Rating for Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549525340?lang=en_us&edition=fundamental","pubTime":"2025-07-08 22:15","pubTimestamp":1751984151,"startTime":"0","endTime":"0","summary":"In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Apogee Therapeutics, with a price target of $96.00. The company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2549541435","title":"Apogee Therapeutics Inc : Jefferies Raises Target Price to $96 From $88","url":"https://stock-news.laohu8.com/highlight/detail?id=2549541435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549541435?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:39","pubTimestamp":1751974763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nFWN3T50C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2549154649","title":"Promising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2549154649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549154649?lang=en_us&edition=fundamental","pubTime":"2025-07-08 18:35","pubTimestamp":1751970916,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison has maintained their bullish stance on APGE stock, giving a Buy rating yesterday. Julian Harrison has given his Buy ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-apogee-therapeutics-apg777-in-atopic-dermatitis-market-drives-buy-rating-and-increased-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-apogee-therapeutics-apg777-in-atopic-dermatitis-market-drives-buy-rating-and-increased-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2549241593","title":"Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2549241593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549241593?lang=en_us&edition=fundamental","pubTime":"2025-07-08 10:46","pubTimestamp":1751942800,"startTime":"0","endTime":"0","summary":"Tim Anderson, an analyst from Bank of America Securities, reiterated the Buy rating on Apogee Therapeutics. The associated price target remains the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apogee-therapeutics-promising-phase-2-results-and-future-growth-potential-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apogee-therapeutics-promising-phase-2-results-and-future-growth-potential-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2549554196","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554196","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549554196?lang=en_us&edition=fundamental","pubTime":"2025-07-08 02:05","pubTimestamp":1751911557,"startTime":"0","endTime":"0","summary":"Core Scientific (CORZ) slid nearly 17% in recent Monday trading following a downgrade to market perform from outperform previously by analysts at Oppenheimer.Trading volume recently topped 82.5 millio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4516","BK4585","APGE","BK4139","BK4608","BK4023","BK4595","CORZ","BK4600","BK4116","BK4588"],"gpt_icon":1},{"id":"2549552890","title":"Optimistic Buy Recommendation for Apogee Therapeutics Driven by Promising APG777 Data and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552890","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549552890?lang=en_us&edition=fundamental","pubTime":"2025-07-08 02:05","pubTimestamp":1751911512,"startTime":"0","endTime":"0","summary":"Analyst Geoff Meacham from Citi maintained a Buy rating on Apogee Therapeutics and keeping the price target at $95.00. Geoff Meacham has given his ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-buy-recommendation-for-apogee-therapeutics-driven-by-promising-apg777-data-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-buy-recommendation-for-apogee-therapeutics-driven-by-promising-apg777-data-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"2549559890","title":"BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549559890?lang=en_us&edition=fundamental","pubTime":"2025-07-08 00:03","pubTimestamp":1751904192,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRockEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nL6N3T40I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0772969993.USD","FICO","DNA","LU0823411888.USD","CVNA","LVWR","VIOT","TSLA","AU","LU1223082519.USD","TSYW.SI","TSCO","MBIO","IONQ","USB","WAI","LU1066051498.USD","STZ","APGE","VOYG","NEM","SKBL","JSPR","BLK","COGT","BTCM","ZEPP","IE00B3QW5Z07.USD","IE00BVYPNW00.USD","MOH","UBER","FBIO","HNGE","RGLD","LU0289960550.SGD","KALV","SG9999018865.SGD","WNS","BK4559","CORZ","LU0203202063.USD"],"gpt_icon":1},{"id":"2549442555","title":"Apogee Therapeutics Shares Reverse Premarket Gains; Last Down 15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549442555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549442555?lang=en_us&edition=fundamental","pubTime":"2025-07-07 23:08","pubTimestamp":1751900936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nL4N3T40YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"1186320939","title":"Stock Track | Apogee Therapeutics Plummets 5.18% Despite Positive Phase 2 Trial Results for Atopic Dermatitis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1186320939","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186320939?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:32","pubTimestamp":1751895169,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (NASDAQ: APGE) saw its stock plummet 5.18% in Monday's pre-market trading, despite announcing positive 16-week data from its Phase 2 APEX clinical trial of APG777, a potential...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["APGE"],"gpt_icon":0},{"id":"1167182133","title":"Stock Track | Apogee Therapeutics Plummets 5.18% Despite Positive Phase 2 Trial Results for Atopic Dermatitis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1167182133","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167182133?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:32","pubTimestamp":1751895161,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) experienced a significant 5.18% drop in its stock price during pre-market trading on Monday, despite announcing positive results from its Phase 2 APEX clinical trial for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["APGE"],"gpt_icon":0},{"id":"2549532608","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Look Ahead to US Trade Pact Announcements","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532608","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549532608?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:34","pubTimestamp":1751891673,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% lower in Monday's premarket activity as investors await the Wh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VHT","XLV","SHEL","APGE",".IXIC","EXI","IBB","XLE","BITO","XLI","RTH","STLA","PMR","VIS","XRT","IYJ","SLV","QQQ","XLK","XSD","XLP","EQR","UNG","IYK","AMAT","IYW","XLF","IYH","IVV","VDC","VHT.AU","FAS","RTH.AU","ISBC","USO","SOXX","SPY.AU","FDN",".SPX","FAZ","SPY","IGV","XLY","IPK",".DJI","IGM"],"gpt_icon":1},{"id":"2549685531","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Constellation Brands, KalVista Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2549685531","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549685531?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:39","pubTimestamp":1751888384,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Constellation Brands, KalVista PharmaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nL6N3T40CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU1145028129.USD","LU2264538146.SGD","LU1861558580.USD","LU2361045086.USD","LU0198837287.USD","LU1069344957.HKD","TSYW.SI","LU0079474960.USD","BK4097","LU0256863811.USD","LU0612318971.USD","LU2552382215.SGD","KALV","LU0082616367.USD","LU2362541273.HKD","WNS","BK4106","LU0719512351.SGD","LU0240878834.USD","BK4139","SG9999004303.SGD","BK4504","BK4154","LU2108987350.USD","NEM","BK4099","LU0215105999.USD","LU0316494557.USD","APGE","BK4550","LU2433249047.HKD","SG9999014021.USD","MOH","STZ","LU2106854487.HKD","IE00BQXX3F31.USD","LU0788109121.HKD","LU2471134952.CNY","SGXZ23171101.USD","LU2125909247.SGD","AU","BK4548","BK4551","SG9999014005.SGD","IE00BQXX3C00.GBP","TSLA"],"gpt_icon":1},{"id":"2549531539","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2549531539","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549531539?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:33","pubTimestamp":1751888017,"startTime":"0","endTime":"0","summary":"SaverOne 2014  shares were up 59% pre-bell Monday following a muted session.Sonnet BioTherapeutics  shares were 31% higher after a 5.5% loss in the previous session.Apogee Therapeutics  stock was up 20% after the company said that part A of a phase 2 trial of APG777 in patients with moderate-to-severe atopic dermatitis met all primary and key secondary endpoints.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE","SONN","BK4139","BK4157","SVRE"],"gpt_icon":0},{"id":"2549416535","title":"Apogee Therapeutics Rise on Positive Data from Dermatitis Treatment Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2549416535","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549416535?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:32","pubTimestamp":1751884320,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares soared in premarket trading Monday after the company said it received positive trial data for its atopic dermatitis treatment.Shares traded 36% higher ahead of the morning bell at $64.45.The clinical stage biopharmaceutical company on Monday said that the second phase of the APEX clinical trial for APG777 met all primary and key secondary endpoints and exceeded trial objectives.The 16-week trial tested the company's treatment for moderate-to-severe atopic dermatitis, a chronic, inflammatory skin condition marked by intense itching, red, inflamed scaly patches that can also interfere with sleep and general quality of life.Some of the findings included efficacy results, which compared favorably to standard care treatments, as well as rapid itch relief and lesion reduction, and a favorable safety profile.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apogee Therapeutics Rise on Positive Data from Dermatitis Treatment Trials","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2549536837","title":"Apogee Therapeutics Reports Positive Phase 2 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2549536837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549536837?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:31","pubTimestamp":1751884313,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics ( ($APGE) ) has shared an announcement. On July 7, 2025, Apogee Therapeutics announced positive 16-week results from Part A of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-positive-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-positive-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2549535576","title":"BUZZ-Apogee Therapeutics jumps after eczema drug meets main goal in mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2549535576","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549535576?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:27","pubTimestamp":1751884061,"startTime":"0","endTime":"0","summary":"BUZZ-Apogee Therapeutics jumps after eczema drug meets main goal in mid-stage study** Shares of drug developer Apogee Therapeutics APGE.O rise 35.9% to $64.50 premarket** Company says its experimental drug met main goal in a mid-stage study to treat patients with moderate-to-severe atopic dermatitis ** AD, or eczema, is a chronic disease that causes inflammation, redness and irritation of skin** Company says the drug, APG777, showed high response rate with a 71% reduction in eczema severity, compared with placebo of 33.8% at week 16 in part-A of the mid-stage study** Company expects to share the 280-patient study data from part-B in mid-2026** As of last close, stock up 4.77% YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nL4N3T40N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU1917777945.USD","LU2023250504.SGD","LU2106854487.HKD","LU0882574055.USD","REGN","LU0823434740.USD","BK4585","LU0823416689.USD","LU0053666078.USD","LU0058720904.USD","LU2362540622.SGD","LU0320765992.SGD","LU0289739699.SGD","LU2089984988.USD","LU0114720955.EUR","APGE","BK4139","LU0109394709.USD","LU0889565916.HKD","BK4588","LU2362541513.USD","LU2468319806.SGD","LU2362541273.HKD","LU2237438978.USD","LU1974910355.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"APGE","fiscalQuarterEnding":"2025/03","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-03-03","symbol":"APGE","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2024-11-12","symbol":"APGE","fiscalQuarterEnding":"2024/09","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.7778,"buy":0.2222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.7778,"analysts":9,"updateTime":1742097600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2025-07-18","current":-11.083176,"percent":0.933472,"low":-42.099968,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"high":-9.181289,"avg":-20.423448,"sd":7.92449,"marketCap":2276384526},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526}],"updateTime":1753137247335}}}